Results (
Russian) 1:
[Copy]Copied!
Senior position within a global Pharmaceutical company. To be considered for this role, the right candidate needs to come from a proven Pricing, Reimbursement & Market Access background, be an established, well connected and recognised industry professional and currently working at Director level (Senior Manager and Associate Director's will also be considered) within a Pharmaceutical or Biotechnology company. You will have a broad therapy background, preferably in one of the following TA's: Oncology, Haematology, CNS, Respiratory, Hepatology, Cardio, VirologySet the strategic direction for regional market access and reimbursement.Able to work strategically and operationallyWork closely with European and Global teams to align market access strategy.Develop robust pricing and reimbursement dossiers. Along with HTA submissions, using economic models and GVD (Global Value Dossiers).Build relationships with key stakeholders to accelerate access to patients.You will have a good understanding of all Health Economic practices - Cost Effectiveness, Payers, HTA, Modelling, Systematic Reviews, Pricing, Reimbursement, Market Access.The position is open to all candidates in The Netherlands, Belgium (Benelux) and Italy - you must be fluent in English, and fluency in other languages would also be an advantage.You will be degree educated and have a minimum of 7 years experience within Market Access, Pricing, Reimbursement.Чтобы применить:Пожалуйста, пришлите Ваше резюме в Cara Nagle на cara.nagle@morganprestwich.comО Морган Прествич:Морган Прествич набора Limited является полностью интегрированной фармацевтических найма консультантов, предоставляя индивидуальные услуги для наших клиентов и кандидатов потребностей на всех уровнях фармацевтической промышленности, биотехнологии, медицинские приборы, клинические исследования и консалтинговой отрасли. Мы работаем глобально, привлекая международных клиентов и кандидатов во всей отрасли. www.morganprestwich.comKeywords: Market Access, MA, MAPR, MAPOR, HEOR, HEPRA, Health Economist, health economics, outcomes research, pricing, reimbursement, market access, Pharmaceutical, pharma, leading pharma, Head of Health Economics, Director, senior, line management, Pricing, PRO, pharmacoeconomics, Belgium, Netherlands, Italy, global, Europe, European, HTA, markov, decision tree, Health Technology, NICE, NHS, systematic literature reviews, retrospective database analyses, prospective studies, cost-effectiveness, budget impact models, HEOR, HEPRA, Health Economist, line management, health economics, outcomes research, pricing, reimbursement, market access, Pharmaceutical, pharma, leading pharma, Head of Health Economics, Director, senior, line management, Pricing, PRO, pharmacoeconomics, Germany, UK, France, Switzerland, global, Europe, European, HTA, markov, decision tree, Health Technology, NICE, NHS, systematic literature reviews, retrospective database analyses, prospective studies, cost-effectiveness, budget impact models, keywords: Health economics, health economist, Health economist manager, health economist director, health economist associate, health economist senior, manger health economist, manager health economics, director health economist, director health economics, VP health economist, VP health economics, vice president health economist, health economist vice president, health economist, vice presidents health economics, health economics vice president, HEOR, heor, he&or, HE&OR, ORHE, OR&HE, health economists, health economist research, health economist HTA, health economics, HTA, HEOR HTA, HE&OR HTA
Being translated, please wait..
